THO
Neutral
Investors are counting down to key consumer inflation data and the Fed's last policy decision of the year.
Investors have fretted that weight-loss drugs were going to overhaul the eating behaviors of consumers, health needs, and even wardrobes. So far, the fears have been overblown.
Novo Nordisk's corporate structure has a few quirks that investors need to know about.
Artificial intelligence’s massive momentum will carry into 2024 and beyond.
Premium analysis from Morningstar & Argus
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|
Symbol | Last Price | Change | % Change |
---|---|---|---|